Безпалько Людмила Васильевна,Ржепецкая Ирина Николаевна,Сова Евгений Александрович,Горбенко Наталия Ивановна,Иванова Ольга Владимировна,Звягина Татьяна Сергеевна,Кобылинская Валентина Ивановна,Тищенко
申请号：
RU2011125805
公开号：
RU2011125805A
申请日:
2011.06.24
申请国别(地区):
RU
年份:
2012
代理人:
摘要：
1. A pharmaceutical composition for preventing and treating metabolic syndrome and diabetic nephropathy comprising the active substance taurine, motherwort herb extract, hawthorn fruit extract and auxiliaries, characterized in that the components are taken in the following ratio, wt%: * - (based on. dry matter) .2. A pharmaceutical composition according to claim 1, characterized in that the dry extracts and hawthorn Leonurus incorporated into the composition in the form of a complex with auxiliary veschestvami.3. The agent for the prophylaxis and treatment of metabolic syndrome and diabetic nephropathy comprising the active substance taurine, herb of Leonurus extract, hawthorn fruit extract and auxiliaries, characterized in that it comprises a pharmaceutical composition in the following ratio, wt%: * - (on a dry basis. substance) .4. A compound according to claim 3, characterized in that as auxiliary substance selected operating functions binders, disintegrants, and materials, glidants and lubricant during compaction of the granulate, and film materials pokrytiya.5. A compound according to claim 4, characterized in that as substances that perform the function of binders comprises potato starch or microcrystalline cellulose to obtain granules for tabletting or kapsulirovaniya.6. A compound according to claim 4, characterized in that as disintegrants, comprises croscarmellose sodium to obtain granules with a liquid or thick or dry vegetable ekstraktami.7. According to claim 4, wherein as materials1. Фармацевтическая композиция для профилактики и лечения метаболического синдрома и диабетической нефропатии, содержащая активные вещества таурин, экстракт травы пустырника, экстракт плодов боярышника и вспомогательные вещества, отличающаяся тем, что компоненты взяты при следующем соотношении, мас.%:* - (в пересчете на сухое вещество).2. Фармацевтическая композиция по п.1, отличающаяся тем, что сухие экстракты боярышника и пустырника введены в состав в виде комплекса со вспо
